What is Precision Medicine? Is It the Cure to Cancer Therapy?

Over the last 10 years cancer treatment has improved dramatically with the introduction of concepts such as precision medicine. Thanks to this new revolutionary approach to treatment, cancer patients can now get treatment that is tailored their tumor’s specific gene mutations, which ultimately results in potentially better outcomes.  If treatment can be tailored, what does this mean for the disease, diagnosis and treatment for individual cancer patients?

Come learn about the new and better approaches to cancer treatment through precision medicine. Dr. Wang will share actual patient cases where this form of therapy was used and the outcomes.

Session participants will learn about:

• What precision medicine or personalized cancer treatment means
• When it is best to use precision medicine and for what cancer types
• Where individualized, precision medicine is taking cancer treatment overall, and how to best prepare for this new form of advanced therapy

About our speaker:

Presenter:

Jue Wang, MD, FACP
Professor of Medicine and Interdisciplinary Oncology
The University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center
Jue.Wang@DignityHealth.org

Jue Wang, MD, FACP, is the Section Leader of the Genitourinary Oncology Division at the University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center. Dr. Wang is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine.

Dr. Wang’s expertise includes the treatment of genitourinary tumors, which includes cancers of the urinary tract and male genital tract, including prostate, bladder, kidney, testicular, urethral and penile cancer. He is a known expert and research in the field of precision medicine and precision oncology. He has published extensively and serves as a chief editor of several academic journals.

He has also done extensive work and research on improving the effectiveness of cancer treatment through genomic-guided precision medicine. He is a member of American Society of Clinical Oncology, International Society of Gastrointestinal Oncology, International Society of Geriatric Oncology, the Alliance for Clinical Trials in Oncology, and is a Professor of Medicine and Interdisciplinary Oncology at the University of Arizona, and Creighton School of Medicine.

For more information, contact Sherry Haskins at:
Telephone: (602)-372-7034
E-Mail: info@healthyazworksites.org